Weigh risk/benefits: Both trusopt and Xalatan (latanoprost) are pregnancy category c.Meaning there are no adequate/well-controlled studies in pregnant women using these drugs, thus these medications should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.Trusopt has been associated with decreased birth weight when studied in rats.Review any options with your doctor.Take care.
Answered 2/9/2017
4.8k views
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
5 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question